As psychedelics enter legal frameworks and wellness routines alike, users are discovering that altered states require an altered set of manners.
In tech boardrooms and boutique retreat centers, in ketamine clinics and dinner party side conversations, psychedelics are no longer whispered about. But that doesn’t mean we know how to speak about them — at least, not without making the room go quiet.
It is now legal in some states to consume psilocybin in supervised settings. MDMA-assisted therapy for PTSD may be FDA-approved as early as this year. Psychedelic clinics are opening in strip malls and strip-mined Instagram feeds. Psychedelic aesthetics — mycelial patterns, tarot motifs, desert moons — have made their way into product packaging for brands selling everything from loungewear to adaptogenic tea.
But when someone shares that they microdosed before a meeting, or returned from a weekend of tripping “to release trauma,” the response is often a beat too slow. A smile that says we don’t quite know how to talk about this yet.
That lack of language hasn’t stopped usage. The global psychedelics market is projected to surpass $11.9 billion by 2029, according to The Business Research Company. In the U.S., a 2023 study published in the International Journal of Drug Policy found that nearly 14 percent of adults have tried psychedelics at least once — up from fewer than ten percent just a decade ago. Meanwhile, more than 500 ketamine clinics are now operating nationwide, blurring the line between medicine and lifestyle.
What these figures signal is not just legitimacy, but access. Their psychedelic narratives are told without stigma. For others — those outside of tech, or outside whiteness, or outside financial security — the decision to share isn’t so simple. There’s a fine line between openness and risk.

For some, psychedelics remain spiritual tools. For others, they’ve become instruments of performance. Microdosing, a sub-perceptual dose of a psychedelic compound like LSD or psilocybin taken for mood and focus, is increasingly popular among high achievers, particularly in the tech world. Employees at companies like Google and Meta have quietly incorporated psychedelics into their weekly routines.
A 2023 PLOS One study found that recent psychedelic users demonstrated more original thinking and greater emotional connectivity. Participants reported using psychedelic drugs made them feel “more connected (to the self, others, and the world),” the study says. “They produced more creative ideas (in terms of originality and fluency), and they showed a trend for more creative activities (but not creative achievements).” But while creativity may increase, so too does vulnerability — and that includes an increasingly visible etiquette gap.
In the elite spheres of entrepreneurship and innovation, psychedelics have been rebranded not as mind-altering escapes but as tools of insight. Apple co-founder, the late Steve Jobs, famously described his LSD experiences as among the “most important” things he ever did. Christian Angermayer, investor and founder of Atai Life Sciences, has spoken extensively about the life-changing effects of his first psilocybin trip — and has since raised over $100 million to fund psychedelic therapeutics. OpenAI CEO Sam Altman has said that psychedelics changed his life; he is now an investor in Journey Colab, a company advancing psychedelic clinical trials.
In many other spaces, psychedelic use has become a kind of soft credential — spoken aloud only when it enhances personal narrative. It might surface in a profile in Fast Company, or in a podcast about founder burnout. But in more intimate settings — family dinners, office chats — the disclosure is often edited, if it appears at all. Etiquette, in this sense, becomes a study in code-switching. In some circles, it’s acceptable to reference mushrooms, but not acid. Ketamine is fine, but only if it was administered in a clinic. Ayahuasca may be revered, but talking about purging in a group chat? Maybe not.
What’s missing is not boldness, but precision: how do you share your psychedelic experience in a way that doesn’t co-opt, overshare, or assume mutual understanding?

In marginalized communities, where the War on Drugs left generational trauma, the line between experience and exposure is razor-thin. While white professionals may discuss tripping at a leadership retreat with relative ease, Black and brown users often carry the added weight of criminalization, even in places where these substances are decriminalized.
In the therapeutic setting, the stakes are even higher. MDMA- and psilocybin-assisted therapy has shown immense potential in early clinical trials. But the very mechanisms that make psychedelics effective — openness, emotional vulnerability, sensory expansion — also require ethical infrastructures that most therapy models weren’t designed to handle.
New standards are emerging. Some training programs now emphasize “living consent,” a model where facilitators check in throughout the session, not just at the outset. Integration support, both peer-led and clinical, is becoming an expectation rather than a bonus. These new rituals form the architecture of trust. And trust, unlike legality, cannot be legislated.

As the number of psychedelic users grows, so too does the conversation around what happens after the ceremony. Integration is no longer confined to therapy rooms or shamanic circles. It’s happening in casual conversations, social media captions, and Slack threads. But like the journeys themselves, not all integrations are created equal.
Oversharing — particularly in mixed company — can flatten what was once sacred. Under-sharing can feel evasive. The challenge is to locate the middle ground between reverence and relatability, between privacy and presence.
Etiquette, at its best, is about care. Not performative politeness, but attentiveness. Psychedelics, for all their radical potential, do not excuse us from social obligation. They intensify it.
In this way, the social etiquette of psychedelics is not a script, but a mirror. It reflects not only how we communicate, but how we listen. Who we trust. Who we invite in. At its best, etiquette is a way of caring for others. It makes room. It signals respect. Psychedelics, for all their power to dissolve the ego, don’t dissolve social context, though. They may even amplify it. The result is a kind of psychedelic closet, where legality exists, but etiquette is still catching up.
Related on Ethos:

